Physician

Anita Marie Basenese, RN, NP, APN-C

According to 2025 Medicare claims, Anita Basenese, RN, NP, APN-C (NPI: 1932411857) practices certified clinical nurse specialist in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Middlesex, NJ. This provider's primary affiliated billing organization is TITAN HEALTH PARTNERS LLC (NPI: 1790396281; TIN: 852303328) and primary practice location at 08816-3340. Basenese is affiliated with the Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Basenese's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 154 traditional Medicare patients, billed 1,082 HCPCS/CPT codes, and received $84,394 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 913 prescription claims across 145 beneficiaries totaling $120,084 in drug costs, led by Oxycontin (Oxycodone Hcl). Open Payments data shows 7 records totaling $132. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $22,206 to $84,394. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	94	283	$22,206
2021	71	260	$20,168
2022	150	566	$63,557
2023	127	621	$60,511
2024	154	1,082	$84,394

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	12	$443
2022	100	526	$22,842
2023	101	637	$67,283
2024	145	913	$120,084

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	79	79	$171
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	111	355	$141
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	53	92	$98
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	30	35	$26
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	125	422	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycontin	Oxycodone Hcl	46	1,290	$85,502
Lidocaine	Lidocaine	44	1,410	$6,226
Oxycodone Hcl	Oxycodone Hcl	102	2,588	$2,870
Megestrol Acetate	Megestrol Acetate	48	1,370	$1,976
Fentanyl	Fentanyl	14	225	$1,189

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$132	Mirati Therapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anita Marie Basenese, RN, NP, APN-C?

Tedicare shows public-source Medicare data for Anita Marie Basenese, RN, NP, APN-C (NPI 1932411857), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anita Marie Basenese, RN, NP, APN-C have ACO affiliation data?

Anita Marie Basenese, RN, NP, APN-C is shown with ACO affiliation data for Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Anita Marie Basenese, RN, NP, APN-C?

Anita Marie Basenese, RN, NP, APN-C is linked to TITAN HEALTH PARTNERS LLC (billing NPI 1790396281) in the available physician profile data.

Does Anita Marie Basenese, RN, NP, APN-C have Open Payments data?

Anita Marie Basenese, RN, NP, APN-C has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.